Briaud Financial Planning’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,536
Closed -$71K 64
2025
Q2
$71K Hold
1,536
0.03% 85
2025
Q1
$93K Hold
1,536
0.04% 52
2024
Q4
$86K Hold
1,536
0.04% 57
2024
Q3
$79K Buy
1,536
+402
+35% +$18.9K 0.04% 48
2024
Q2
$47K Hold
1,134
0.03% 58
2024
Q1
$62K Buy
+1,134
New +$57.8K 0.04% 50
2023
Q4
Sell
-1,240
Closed -$71K 34
2023
Q3
$71K Buy
+1,240
New +$76K 0.06% 49

Other funds holding BMY

Briaud Financial Planning's BMY Position: Q3 2025 in Review

Briaud Financial Planning sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 1,536 shares — an estimated $71K sold.

Briaud Financial Planning first reported a position in BMY in Q3 2023 and held it in 7 quarters. The position peaked at $93K in Q1 2025. 2,274 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • Briaud Financial Planning reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
  • Briaud Financial Planning sold 1,536 Bristol-Myers Squibb shares in Q3 2025, an estimated $71K.
  • Briaud Financial Planning first reported a position in Bristol-Myers Squibb in Q3 2023 and held it in 7 quarters.
  • Briaud Financial Planning's Bristol-Myers Squibb position peaked at $93K in Q1 2025.
  • 2,274 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Briaud Financial Planning's 13F filing for Q3 2025, filed 25 Nov 2025.